These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16269280)

  • 1. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.
    Schröder-Borm H; Bakalova R; Andrä J
    FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
    Papo N; Shai Y
    Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
    Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
    Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine.
    Banerjee A; Roychoudhury J; Ali N
    J Antimicrob Chemother; 2008 Jan; 61(1):103-10. PubMed ID: 17965031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
    Wilms D; Andrä J
    J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human opioid peptide Met-enkephalin binds to anionic phosphatidylserine in high preference to zwitterionic phosphatidylcholine: natural-abundance 13C NMR study on the binding state in large unilamellar vesicles.
    Kimura T
    Biochemistry; 2006 Dec; 45(51):15601-9. PubMed ID: 17176081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of amoebapores and NK-lysin with symmetric phospholipid and asymmetric lipopolysaccharide/phospholipid bilayers.
    Gutsmann T; Riekens B; Bruhn H; Wiese A; Seydel U; Leippe M
    Biochemistry; 2003 Aug; 42(32):9804-12. PubMed ID: 12911324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin.
    Schröder-Borm H; Willumeit R; Brandenburg K; Andrä J
    Biochim Biophys Acta; 2003 Jun; 1612(2):164-71. PubMed ID: 12787934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface.
    Iwasaki T; Ishibashi J; Tanaka H; Sato M; Asaoka A; Taylor D; Yamakawa M
    Peptides; 2009 Apr; 30(4):660-8. PubMed ID: 19154767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of histone H1 with phospholipids and comparison of its binding to giant liposomes and human leukemic T cells.
    Zhao H; Bose S; Tuominen EK; Kinnunen PK
    Biochemistry; 2004 Aug; 43(31):10192-202. PubMed ID: 15287747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
    Xu FY; Queen G; Brandes L; Hatch GM
    Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.
    Desai TJ; Udugamasooriya DG
    Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane phosphatidylserine regulates surface charge and protein localization.
    Yeung T; Gilbert GE; Shi J; Silvius J; Kapus A; Grinstein S
    Science; 2008 Jan; 319(5860):210-3. PubMed ID: 18187657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of peptide vectors for gene delivery with active targeting profiles for phosphatidylserine.
    Kuriyama S; Taguchi Y; Nishimura K; Yanagibashi K; Katayama Y; Niidoime T
    J Pept Sci; 2009 Feb; 15(2):114-9. PubMed ID: 19090508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.
    Gelhaus C; Jacobs T; Andrä J; Leippe M
    Antimicrob Agents Chemother; 2008 May; 52(5):1713-20. PubMed ID: 18332165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of chicken NK-lysin.
    Hong YH; Lillehoj HS; Dalloul RA; Min W; Miska KB; Tuo W; Lee SH; Han JY; Lillehoj EP
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):339-47. PubMed ID: 16387367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface exposure of phosphatidylserine in pathological cells.
    Zwaal RF; Comfurius P; Bevers EM
    Cell Mol Life Sci; 2005 May; 62(9):971-88. PubMed ID: 15761668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
    Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
    PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chicken NK-lysin is an alpha-helical cationic peptide that exerts its antibacterial activity through damage of bacterial cell membranes.
    Lee MO; Jang HJ; Han JY; Womack JE
    Poult Sci; 2014 Apr; 93(4):864-70. PubMed ID: 24706963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.